These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study. Schroeder H, Meyer DR, Lux B, Ruecker F, Martorana M, Duda S. Catheter Cardiovasc Interv; 2015 Aug; 86(2):278-86. PubMed ID: 25708850 [Abstract] [Full Text] [Related]
5. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease. Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K. J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972 [Abstract] [Full Text] [Related]
6. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population. Chen Z, Guo W, Jiang W, Wang F, Fu W, Zou Y, Deckers S, Li P, Popma JJ, Jaff MR. J Endovasc Ther; 2019 Aug; 26(4):471-478. PubMed ID: 31204595 [Abstract] [Full Text] [Related]
7. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort. Brodmann M, Keirse K, Scheinert D, Spak L, Jaff MR, Schmahl R, Li P, Zeller T, IN.PACT Global Study Investigators. JACC Cardiovasc Interv; 2017 Oct 23; 10(20):2113-2123. PubMed ID: 29050631 [Abstract] [Full Text] [Related]
8. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry. Stabile E, Gerardi D, Magliulo F, Zhelev D, Chervenkoff V, Taeymans K, Kotasov D, Goverde P, Giugliano G, Trimarco B, Esposito G. J Endovasc Ther; 2019 Feb 23; 26(1):26-30. PubMed ID: 30760132 [Abstract] [Full Text] [Related]
9. The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon. Thieme M, Von Bilderling P, Paetzel C, Karnabatidis D, Perez Delgado J, Lichtenberg M, Lutonix Global SFA Registry Investigators. JACC Cardiovasc Interv; 2017 Aug 28; 10(16):1682-1690. PubMed ID: 28780030 [Abstract] [Full Text] [Related]
10. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial. Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H, MDT-2113 SFA Japan Investigators. J Endovasc Ther; 2018 Feb 28; 25(1):109-117. PubMed ID: 29264999 [Abstract] [Full Text] [Related]
16. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions. Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G. Circ Cardiovasc Interv; 2019 Jun 28; 12(6):e007702. PubMed ID: 31195825 [Abstract] [Full Text] [Related]
17. Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial. Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H, MDT-2113 SFA Japan Investigators. Catheter Cardiovasc Interv; 2019 Mar 01; 93(4):664-672. PubMed ID: 30747489 [Abstract] [Full Text] [Related]
18. 2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study. Micari A, Nerla R, Vadalà G, Castriota F, Grattoni C, Liso A, Russo P, Pantaleo P, Roscitano G, Cremonesi A. JACC Cardiovasc Interv; 2017 Apr 10; 10(7):728-734. PubMed ID: 28385412 [Abstract] [Full Text] [Related]